BIOMAT Database Logo BIOMAT Database Logo

Vasoactive intestinal peptide as a healing mediator in Crohn's disease. 2008

A Arranz, and C Abad, and Y Juarranz, and J Leceta, and C Martinez, and R P Gomariz
Departamento de Biología Celular, Facultad de Biología, Universidad Complutense de Madrid, Madrid, Spain.

The vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide (VIP/PACAP) system is considered as a paradigm for the use of a neuroendocrine-immune mediator in therapy. We review the role of VIP in 2,4,6-trinitrobenzenesulfonic acid (TNBS)-induced colitis as a murine model of Crohn's disease. VIP treatment led to the recovery of clinical factors, the amelioration of parameters related to the recruitment and traffic of cell populations, and the balance of inflammatory mediators derived from granulocytes, antigen-presenting cells and T lymphocytes including Th1, Th2 and Th17. Finally, the most recent data validate its therapeutic role through the modulation of TLR2 and 4 receptors.

UI MeSH Term Description Entries
D009490 Neurosecretory Systems A system of NEURONS that has the specialized function to produce and secrete HORMONES, and that constitutes, in whole or in part, an ENDOCRINE SYSTEM or organ. Neuroendocrine System,Neuroendocrine Systems,Neurosecretory System,System, Neuroendocrine,System, Neurosecretory,Systems, Neuroendocrine,Systems, Neurosecretory
D003424 Crohn Disease A chronic transmural inflammation that may involve any part of the DIGESTIVE TRACT from MOUTH to ANUS, mostly found in the ILEUM, the CECUM, and the COLON. In Crohn disease, the inflammation, extending through the intestinal wall from the MUCOSA to the serosa, is characteristically asymmetric and segmental. Epithelioid GRANULOMAS may be seen in some patients. Colitis, Granulomatous,Enteritis, Granulomatous,Enteritis, Regional,Ileitis, Regional,Ileitis, Terminal,Ileocolitis,Crohn's Disease,Crohn's Enteritis,Inflammatory Bowel Disease 1,Regional Enteritis,Crohns Disease,Granulomatous Colitis,Granulomatous Enteritis,Regional Ileitides,Regional Ileitis,Terminal Ileitis
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D006098 Granulocytes Leukocytes with abundant granules in the cytoplasm. They are divided into three groups according to the staining properties of the granules: neutrophilic, eosinophilic, and basophilic. Mature granulocytes are the NEUTROPHILS; EOSINOPHILS; and BASOPHILS. Granulocyte
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000938 Antigen-Presenting Cells A heterogeneous group of immunocompetent cells that mediate the cellular immune response by processing and presenting antigens to the T-cells. Traditional antigen-presenting cells include MACROPHAGES; DENDRITIC CELLS; LANGERHANS CELLS; and B-LYMPHOCYTES. FOLLICULAR DENDRITIC CELLS are not traditional antigen-presenting cells, but because they hold antigen on their cell surface in the form of IMMUNE COMPLEXES for B-cell recognition they are considered so by some authors. Accessory Cells, Immunologic,Antigen-Presenting Cell,Immunologic Accessory Cells,Accessory Cell, Immunologic,Cell, Immunologic Accessory,Cells, Immunologic Accessory,Immunologic Accessory Cell,Antigen Presenting Cell,Antigen Presenting Cells,Cell, Antigen-Presenting,Cells, Antigen-Presenting
D013601 T-Lymphocytes Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen. T Cell,T Lymphocyte,T-Cells,Thymus-Dependent Lymphocytes,Cell, T,Cells, T,Lymphocyte, T,Lymphocyte, Thymus-Dependent,Lymphocytes, T,Lymphocytes, Thymus-Dependent,T Cells,T Lymphocytes,T-Cell,T-Lymphocyte,Thymus Dependent Lymphocytes,Thymus-Dependent Lymphocyte
D014660 Vasoactive Intestinal Peptide A highly basic, 28 amino acid neuropeptide released from intestinal mucosa. It has a wide range of biological actions affecting the cardiovascular, gastrointestinal, and respiratory systems and is neuroprotective. It binds special receptors (RECEPTORS, VASOACTIVE INTESTINAL PEPTIDE). VIP (Vasoactive Intestinal Peptide),Vasoactive Intestinal Polypeptide,Vasointestinal Peptide,Intestinal Peptide, Vasoactive,Intestinal Polypeptide, Vasoactive,Peptide, Vasoactive Intestinal,Peptide, Vasointestinal,Polypeptide, Vasoactive Intestinal
D015213 Neuroimmunomodulation The biochemical and electrophysiological interactions between the NERVOUS SYSTEM and IMMUNE SYSTEM. Cholinergic Anti-inflammatory Pathway,Neuro-immune Axis,Neuro-immune Communication,Neuro-immune Interactions,Neuro-immunomodulation,Neuroimmune Axis,Neuroimmune Communication,Neuroimmune Interactions,Neuroimmune Processes,Vagal Anti-inflammatory Pathway,Vagal-immune Interactions,Neuroimmune Mechanisms,Neuroimmune Process,Anti-inflammatory Pathway, Cholinergic,Anti-inflammatory Pathway, Vagal,Cholinergic Anti inflammatory Pathway,Cholinergic Anti-inflammatory Pathways,Communication, Neuro-immune,Communication, Neuroimmune,Interaction, Neuro-immune,Interaction, Neuroimmune,Mechanism, Neuroimmune,Neuro immune Axis,Neuro immune Communication,Neuro immune Interactions,Neuro immunomodulation,Neuro-immune Communications,Neuro-immune Interaction,Neuroimmune Communications,Neuroimmune Interaction,Neuroimmune Mechanism,Process, Neuroimmune,Vagal Anti inflammatory Pathway,Vagal Anti-inflammatory Pathways,Vagal immune Interactions,Vagal-immune Interaction

Related Publications

A Arranz, and C Abad, and Y Juarranz, and J Leceta, and C Martinez, and R P Gomariz
Vasoactive intestinal peptide as a neural mediator of gastric relaxation.
January 1985, The American journal of physiology,
A Arranz, and C Abad, and Y Juarranz, and J Leceta, and C Martinez, and R P Gomariz
Dual actions of S-nitrosylated derivative of vasoactive intestinal peptide as a vasoactive intestinal peptide-like mediator and a nitric oxide carrier.
January 1999, European journal of pharmacology,
A Arranz, and C Abad, and Y Juarranz, and J Leceta, and C Martinez, and R P Gomariz
Vasoactive intestinal polypeptide as mediator of asthma.
January 2001, Pulmonary pharmacology & therapeutics,
A Arranz, and C Abad, and Y Juarranz, and J Leceta, and C Martinez, and R P Gomariz
Vasoactive intestinal peptide as a mediator of the effects of a supergene on social behaviour.
April 2020, Proceedings. Biological sciences,
A Arranz, and C Abad, and Y Juarranz, and J Leceta, and C Martinez, and R P Gomariz
Colonic peristaltic reflex: identification of vasoactive intestinal peptide as mediator of descending relaxation.
July 1986, The American journal of physiology,
A Arranz, and C Abad, and Y Juarranz, and J Leceta, and C Martinez, and R P Gomariz
Vasoactive Intestinal Peptide Promotes Fracture Healing in Sympathectomized Mice.
July 2021, Calcified tissue international,
A Arranz, and C Abad, and Y Juarranz, and J Leceta, and C Martinez, and R P Gomariz
Vasoactive intestinal peptide as a coronary vasodilator.
January 1988, Annals of the New York Academy of Sciences,
A Arranz, and C Abad, and Y Juarranz, and J Leceta, and C Martinez, and R P Gomariz
Vasoactive intestinal peptide: mediator of laminin synthesis in cultured Schwann cells.
February 1996, Journal of neuroscience research,
A Arranz, and C Abad, and Y Juarranz, and J Leceta, and C Martinez, and R P Gomariz
Vasoactive intestinal peptide family as a therapeutic target for Parkinson's disease.
October 2005, Expert opinion on therapeutic targets,
A Arranz, and C Abad, and Y Juarranz, and J Leceta, and C Martinez, and R P Gomariz
Vasoactive intestinal peptide is a local mediator in a gut-brain neural axis activating intestinal gluconeogenesis.
March 2015, Neurogastroenterology and motility,
Copied contents to your clipboard!